P982: MYELOID-DERIVED SUPPRESSOR CELLS: CHARACTERIZATION IN PERIPHERAL BLOOD AND SPLEEN TISSUE OF PATIENTS WITH MYELOFIBROSIS

P982: MYELOID-DERIVED SUPPRESSOR CELLS: CHARACTERIZATION IN PERIPHERAL BLOOD AND SPLEEN TISSUE OF PATIENTS WITH MYELOFIBROSIS

Bibliographic Details
Main Authors:	R. Campanelli, A. Bonometti, M. Massa, C. Abbà, L. Villani, A. Carolei, P. Catarsi, M. Paulli, G. Barosi, E. Boveri, V. Rosti
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000846796.03903.f4

Similar Items

Clinical Relevance of <i>VEGFA</i> (rs3025039) +936 C>T Polymorphism in Primary Myelofibrosis: Susceptibility, Clinical Co-Variates, and Outcomes
by: Laura Villani, et al.
Published: (2021-08-01)

VEGFA rs3025039 is associated with phenotype severity of myelofibrosis‐type megakaryocyte dysplasia
by: Giovanni Barosi, et al.
Published: (2023-08-01)

Type 1 CALR mutation allele frequency correlates with CD34/CXCR4 expression in myelofibrosis-type megakaryocyte dysplasia: A mechanism of disease progression?
by: Giovanni Barosi, et al.
Published: (2024-01-01)

New Markers of Disease Progression in Myelofibrosis
by: Rita Campanelli, et al.
Published: (2021-10-01)

Impact of the rs1024611 Polymorphism of <i>CCL2</i> on the Pathophysiology and Outcome of Primary Myelofibrosis
by: Elena Masselli, et al.
Published: (2021-05-01)

Spleen in myeloproliferative neoplasms
by: Giovanni Barosi
Published: (2018-06-01)

Arginase‐1+ bone marrow myeloid cells are reduced in myeloproliferative neoplasms and correlate with clinical phenotype, fibrosis, and molecular driver
by: Arturo Bonometti, et al.
Published: (2023-04-01)

Elevated plasma EDA fibronectin in primary myelofibrosis is determined by high allele burden of JAK2V617F mutation and strongly predicts splenomegaly progression
by: Alessandro Malara, et al.
Published: (2022-09-01)

Phototheranostics of Splenic Myeloid-Derived Suppressor Cells and Its Impact on Spleen Metabolism in Tumor-Bearing Mice
by: James D. Barnett, et al.
Published: (2022-07-01)

P1039: PALPABLE SPLEEN SIZE IS PROGNOSTIC IN PRIMARY BUT NOT SECONDARY MYELOFIBROSIS
by: M. Lucijanic, et al.
Published: (2022-06-01)

Expansion of myeloid-derived suppressor cells in the peripheral blood of patients with ankylosing spondylitis
by: A. Yu. Morenkova, et al.
Published: (2021-05-01)

Annual technical report (l982)
by: Yang, T.F., et al.
Published: (2015)

CLINICAL AND PATHOMORPHOLOGICAL EXAMINATION OF MYELOFIBROSIS IN CHRONIC MYELOID LEUKEMIA
by: T. Yu. Dolgikh, et al.
Published: (2016-02-01)

P1037: CONSISTENCY OF PACRITINIB FOR SPLEEN AND SYMPTOM REDUCTION IN PATIENTS WITH MYELOFIBROSIS REGARDLESS OF CYTOPENIAS
by: Nico Gagelmann, et al.
Published: (2023-08-01)

Myeloid Metaplasia of Spleen in Hookworm Disease
by: W. O. Cruz
Published: (1934-06-01)

Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis
by: Celia Camacho-Toledano, et al.
Published: (2022-11-01)

Circulating Mesenchymal Stromal Cells in Patients with Infantile Hemangioma: Evaluation of Their Functional Capacity and Gene Expression Profile
by: Carlotta Abbà, et al.
Published: (2024-01-01)

Myeloid-Derived Suppressor Cells (MDSCs) in Haematology
by: Nikoleta Bizymi, et al.
Published: (2021-12-01)

Acute Myeloid Leukemia with Isolated Trisomy 19 Associated with Diffuse Myelofibrosis and Osteosclerosis
by: Adam Stelling, et al.
Published: (2015-12-01)

P1007: SPLENOMEGALY DEVELOPMENT PRECEDES THE PROGRESS OF HEMATOPOIETIC STEM CELLS MIGRATION TO SPLEEN IN MURINE MYELOFIBROSIS MODELS
by: Toshikuni Kawamura, et al.
Published: (2023-08-01)

From primary myelofibrosis to chronic myeloid leukemia, BCR::ABL1+ B‐Lymphoblastic leukemia, and back to primary myelofibrosis: An illustration of dynamic clonal evolution
by: Devin Wang, et al.
Published: (2024-02-01)

Myeloid-Derived Suppressor Cells in Solid Tumors
by: Tianmiao Ma, et al.
Published: (2022-01-01)

Myeloid-derived suppressor cells and pulmonary hypertension
by: Hui Zhang, et al.
Published: (2023-06-01)

Myeloid-Derived Suppressor Cells in Colorectal Cancer
by: Izabela Sieminska, et al.
Published: (2020-08-01)

Development of JAK2 positive myelofibrosis on a background of chronic myeloid leukaemia
by: Christopher Gerard Mullen, et al.
Published: (2022-11-01)

CD115− monocytic myeloid-derived suppressor cells are precursors of OLFM4high polymorphonuclear myeloid-derived suppressor cells
by: Yunyun Zou, et al.
Published: (2023-03-01)

The Palermo Qurʾān (AH373/982–83AD) and its historical context
by: Johns, J
Published: (2017)

Sickle cell disease and pregnancy profile of complicated malaria in 982 pregnancies in Kinshasa
by: Tite Minga Mikobi, et al.
Published: (2022-01-01)

Sickle cell disease and pregnancy profile of complicated malaria in 982 pregnancies in Kinshasa.
by: Tite Minga Mikobi, et al.
Published: (2022-01-01)

Phenotypic and transcriptomic characterization of canine myeloid-derived suppressor cells
by: Goulart, MR, et al.
Published: (2019)

Myeloid-Derived Suppressor Cells and Mesenchymal Stem/Stromal Cells in Myeloid Malignancies
by: Suncica Kapor, et al.
Published: (2021-06-01)

P752: TRANSCRIPTOMIC ANALYSIS OF MYELOID-DERIVED SUPPRESSOR CELLS (MDSCS) IN THE PERIPHERAL BLOOD OF PATIENTS WITH CHRONIC IDIOPATHIC NEUTROPENIA (CIN)
by: Nikoleta Bizymi, et al.
Published: (2023-08-01)

Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer
by: Andrew M. K. Law, et al.
Published: (2020-02-01)

P1061: INDIRECT TREATMENT COMPARISONS OF FEDRATINIB VERSUS NAVITOCLAX PLUS RUXOLITINIB: EFFECT ON SPLEEN VOLUME AND SYMPTOMS IN RUXOLITINIB-EXPOSED MYELOFIBROSIS PATIENTS
by: P. Abraham, et al.
Published: (2022-06-01)

Role of myeloid-derived suppressor cells in chronic brucellosis
by: Shuiping Hou, et al.
Published: (2024-01-01)

The Roles of Myeloid-Derived Suppressor Cells in Liver Disease
by: Chunye Zhang, et al.
Published: (2024-01-01)

Targeting Myeloid-Derived Suppressor Cells in Ovarian Cancer
by: Seiji Mabuchi, et al.
Published: (2021-02-01)

Targeting Myeloid-Derived Suppressor Cells in Cancer Immunotherapy
by: Yufei Wang, et al.
Published: (2020-09-01)

Decoding the Myeloid-Derived Suppressor Cells in Lymphoid Malignancies
by: Iosif Papafragkos, et al.
Published: (2021-08-01)

The role of myeloid-derived suppressor cells in liver cancer
by: Shiyue Zhou, et al.
Published: (2023-05-01)